NCCN Guidelines for Patients® | Multiple Myeloma

27 NCCN Guidelines for Patients ® : Multiple Myeloma, 2019 3 Myeloma treatments Surgery Guide 2. Drug treatment for multiple myeloma Generic name Brand name (sold as) Type of treatment Bendamustine Bendeka,™ Treanda ® Chemotherapy Bortezomib Velcade ® Targeted therapy (proteasome inhibitor) Carfilzomib Kyprolis ® Targeted therapy (proteasome inhibitor) Cisplatin – Chemotherapy Cyclophosphamide – Chemotherapy Daratumumab Darzalex ® Monoclonal antibody Dexamethasone – Steroid Doxorubicin hydrochloride – Chemotherapy Doxorubicin hydrochloride liposome DOXIL ® Chemotherapy Elotuzumab Empliciti™ Monoclonal antibody Etoposide Etopophos ® Chemotherapy Ixazomib Ninlaro ® Targeted therapy (proteasome inhibitor) Lenalidomide Revlimid ® Immunomodulator Melphalan Alkeran ® Chemotherapy Panobinostat Farydak ® Targeted therapy (HDAC [ h istone d e ac etylase] inhibitor) Pomalidomide Pomalyst ® Immunomodulator Thalidomide Thalomid ® Immunomodulator

RkJQdWJsaXNoZXIy NTYwNTM=